期刊文献+

静脉输液风险环节及内容确立 被引量:17

Determination of risk factors and contents of intravenous infusion
下载PDF
导出
摘要 目的通过专家咨询法确定静脉输液的风险环节及内容,为静脉输液管理和培训提供依据。方法 2011年6—9月选择上海市1所大学护理学院及8所3级甲等医院专家共11名,采用函询法对专家进行2轮咨询,内容包括静脉输液的风险环节及内容。结果 2轮专家咨询的应答率均为100%,专家的权威程度Cr=0.931 8,变异系数<0.5的指标占88%,最终确定的静脉输液风险环节及内容由9项1级指标和26项2级指标、66项3级指标构成。结论通过研究形成完善的静脉输液风险环节及内容,可引导临床静脉输液护理实践者及护理管理者及时发现静脉输液风险所在,有助于静脉输液的管理和静脉输液护士的培训。 Objective To determine the risk factors and contents of intravenous infusion by expert consultation. Methods From June to September 2011 a total of 11 experts from one school of nursing and 8 grade A tertiary hospitals were chosen for two rounds of expert consultation by letters of inquiry, Results The response rates of two rounds of expert consultation were both 100%. The specialist authority coefficient was 0. 931 8. The inde- xes with variation coefficient below 0.5 occupied 88%. The risk factors and contents of intravenous infusion were finally determined, including 9 first-level indicators, 26 second-level indicators, and 66 third-level indica- tors. Conclusion The thorough risk factors and contents of intravenous infusion established in the present study can guide clinical intravenous infusion care practitioners and nursing managers in timely finding intravenous infusion risks, and are helpful in intravenous infusion management and nurse training.
出处 《上海护理》 2012年第1期5-8,共4页 Shanghai Nursing
基金 上海市卫生局科研课题基金资助(基金编号:SW273)
关键词 静脉输液 风险 专家咨询 Intravenous infusion Risk Expert consultation
  • 相关文献

参考文献5

  • 1Schumacher DL.Teaching tips:do your CATS PRRR?:a mnemonic device to teach safety checks for administering intravenous medications[J].J Contin Edu Nurs,2005,36(3):104-106.
  • 2Williams CK,Maddox RR.Implementation of an i.v.medication safety system[J].Am J Health Syst Pharm,2005,62 (5):530-536.
  • 3Ingram P,Lavery I.Peripheral intravenous therapy:key risks and implications for practice[J].Nurs Stand,2005,19 (46):55-64,66.
  • 4de Lemos ML,Hamata L,Vu T.Leaching of diethylhexyl phthalate from polyvinyl chloride materials into etoposide intravenous solutions[J].J Oncol Pharm Pract,2005,11 (4):155-157.
  • 5Gabriel J.Infusion therapy part one:minimising the risks[J].Nurs Stand,2008,22(31):51-56,58.

同被引文献115

引证文献17

二级引证文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部